IDEAYA Biosciences appoints Andres Ruiz Briseno as Principal Accounting Officer

IDEAYA Biosciences, Inc.

Andres Ruiz Briseno appointed Principal Accounting Officer, effective July 1, 2023, and promoted to SVP, Head of Finance and Investor Relations.
Mr. Briseno brings over 10 years of finance experience, previously Senior VP at Neumora Therapeutics, and earlier roles at Pharmacyclics.
Received option to purchase 22,500 shares at exercise price $23.23 (closing price on June 29, 2023).
Amended employment agreement includes base salary, target cash incentive, and severance benefits; summary to be filed in Q2 2023 10-Q.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Andres Ruiz Briseno

Principal Accounting Officer

IDYA · IDEAYA Biosciences, Inc.

Effective: 2023-07-01
Filed: July 3, 2023, 7:59 PM ET

appointed Andres Ruiz Briseno as Principal Accounting Officer of the Company, effective July 1, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andres Ruiz Briseno was appointed as Principal Accounting Officer at IDEAYA Biosciences, Inc..

Action: appointed
Role: Principal Accounting Officer

Exact text from the filing

appointed Andres Ruiz Briseno as Principal Accounting Officer of the Company, effective July 1, 2023

View on SEC.gov

IDEAYA Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-181337

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.